Abicipar Phase 2 MAPLE Trial: Evaluation of All Patients With Post-Injection Inflammation

Related

• 

  Characteristics and Outcomes of nAMD Patients Managed in US Routine Clinical Practice: Analysis of the IRIS Registry Database

  Anita Barikian, MD

  Annual Meeting Talks

  2022

• 

  Home OCT and Artificial Intelligence in Neovascular AMD

  Miguel A. Busquets, MD, FACS

  Annual Meeting Talks

  2023

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024